{"id":3524,"date":"2023-03-03T17:32:40","date_gmt":"2023-03-03T16:32:40","guid":{"rendered":"https:\/\/www.access2meds.eu\/impact\/"},"modified":"2025-06-24T09:56:05","modified_gmt":"2025-06-24T07:56:05","slug":"impact","status":"publish","type":"page","link":"https:\/\/www.access2meds.eu\/fr\/impact\/","title":{"rendered":"Impact"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbHeader\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bb2e264158-b54d-4d7f-8146-8c8b7ca64cef\u00a0\u00bb background_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1132274611_iStock_PeopleImages.jpg\u00a0\u00bb background_position=\u00a0\u00bbtop_center\u00a0\u00bb hover_enabled=\u00a0\u00bb0&Prime; global_colors_info=\u00a0\u00bb{}\u00a0\u00bb background_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb sticky_enabled=\u00a0\u00bb0&Prime; title_text=\u00a0\u00bbMobile Header\u00a0\u00bb background_image_phone=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/06\/Mobile-Header.png\u00a0\u00bb background_enable_image_phone=\u00a0\u00bbon\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_padding=\u00a0\u00bb7px|30px||30px|false|true\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_font=\u00a0\u00bb|700||on|||||\u00a0\u00bb header_font_size=\u00a0\u00bb80px\u00a0\u00bb custom_margin=\u00a0\u00bb11px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h1><span style=\"color: #e95f6c;\">Impact<\/span> <\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_color=\u00a0\u00bb#e1e2ed\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb||37px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row module_class=\u00a0\u00bbrowmitklapptext\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_2_font=\u00a0\u00bb|600||on|||||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h2>L&rsquo;impact d&rsquo;ASCERTAIN sur les principaux acteurs du secteur de la sant\u00e9<\/h2>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>Le projet ASCERTAIN s&rsquo;adresse \u00e0 de multiples acteurs du secteur des soins de sant\u00e9, chacun ayant des besoins et des objectifs uniques.<\/p>\n<p>Pour les <strong>industriels<\/strong>, ASCERTAIN propose des recommandations pour l\u2019\u00e9valuation des technologies de la sant\u00e9 (ETS) et apporte de nouvelles connaissances sur la cr\u00e9ation de valeur, la tarification et l\u2019acc\u00e8s. Le projet vise \u00e0 aider l\u2019industrie \u00e0 prendre des d\u00e9cisions \u00e9clair\u00e9es concernant l\u2019accessibilit\u00e9 et la durabilit\u00e9 des technologies de sant\u00e9 innovantes (IHT). <\/p>\n<p>Les <strong>patients<\/strong> b\u00e9n\u00e9ficient du projet ASCERTAIN, qui vise \u00e0 acc\u00e9l\u00e9rer l&rsquo;acc\u00e8s aux technologies de sant\u00e9 innovantes et \u00e0 garantir une tarification \u00e9quitable. Le projet vise \u00e0 am\u00e9liorer le caract\u00e8re abordable et l&rsquo;accessibilit\u00e9 des technologies de sant\u00e9 innovantes et \u00e0 faire en sorte que les patients puissent b\u00e9n\u00e9ficier des derni\u00e8res avanc\u00e9es en mati\u00e8re de soins de sant\u00e9. <\/p>\n<p>Les <strong>chercheurs<\/strong> trouveront le projet ASCERTAIN particuli\u00e8rement utile car il offre un acc\u00e8s libre aux donn\u00e9es et un outil de politique d&rsquo;acc\u00e8s libre. L&rsquo;objectif du projet est de fournir aux chercheurs des informations pr\u00e9cieuses sur le d\u00e9veloppement de nouveaux mod\u00e8les de tarification et de remboursement et de soutenir l&rsquo;avancement de la recherche dans le domaine des soins de sant\u00e9. <\/p>\n<p>Les <strong>d\u00e9cideurs politiques et les gouvernements<\/strong> b\u00e9n\u00e9ficieront des recommandations du projet ASCERTAIN pour la mod\u00e9lisation du rapport rentabilit\u00e9, du remboursement et de l\u2019impact budg\u00e9taire. Le projet fournit des outils d\u2019aide \u00e0 la d\u00e9cision qui peuvent \u00e9clairer le processus d\u00e9cisionnel au niveau gouvernemental et contribuer \u00e0 garantir que les fonds publics sont utilis\u00e9s de la mani\u00e8re la plus efficace possible. <\/p>\n<p>Les organismes de <strong>r\u00e9glementation<\/strong> b\u00e9n\u00e9ficieront des efforts du projet ASCERTAIN pour attribuer des \u00e9tiquettes de valeur aux technologies de la sant\u00e9. Le projet vise \u00e0 fournir aux organismes de r\u00e9glementation des informations qui peuvent les aider \u00e0 prendre des d\u00e9cisions \u00e9clair\u00e9es sur la tarification et le remboursement des nouvelles technologies de la sant\u00e9. <\/p>\n<p>Les <strong>cliniciens<\/strong> b\u00e9n\u00e9ficieront des efforts du projet ASCERTAIN pour am\u00e9liorer le co\u00fbt et l&rsquo;accessibilit\u00e9 des technologies de sant\u00e9 innovantes. Les patients pourront ainsi acc\u00e9der aux derni\u00e8res avanc\u00e9es en mati\u00e8re de soins de sant\u00e9, ce qui am\u00e9liorera la qualit\u00e9 des soins qui leur sont prodigu\u00e9s. <\/p>\n<p><strong>Les payeurs et les<\/strong> compagnies d&rsquo;<strong>assurance<\/strong> b\u00e9n\u00e9ficieront des efforts du projet ASCERTAIN pour fournir un outil complet d&rsquo;aide \u00e0 la d\u00e9cision. Le projet vise \u00e0 aider les autorit\u00e9s sanitaires, les assureurs et les prestataires de soins de sant\u00e9 \u00e0 prendre des d\u00e9cisions \u00e9clair\u00e9es sur la tarification et le remboursement des technologies de sant\u00e9 innovantes. <\/p>\n<p>Le <strong>grand public<\/strong> devrait \u00e9galement b\u00e9n\u00e9ficier du projet ASCERTAIN. Les efforts du projet pour am\u00e9liorer le caract\u00e8re abordable et l&rsquo;accessibilit\u00e9 des technologies de sant\u00e9 innovantes contribueront \u00e0 garantir que les fonds publics sont utilis\u00e9s de la mani\u00e8re la plus efficace possible et que les patients peuvent acc\u00e9der aux derni\u00e8res avanc\u00e9es en mati\u00e8re de soins de sant\u00e9. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; module_id=\u00a0\u00bbcontact\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_color=\u00a0\u00bb#86B8BD\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb16px||75px||false|false\u00a0\u00bb box_shadow_style=\u00a0\u00bbpreset7&Prime; box_shadow_horizontal=\u00a0\u00bb0px\u00a0\u00bb box_shadow_vertical=\u00a0\u00bb-274px\u00a0\u00bb box_shadow_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb global_module=\u00a0\u00bb910&Prime; saved_tabs=\u00a0\u00bball\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_font=\u00a0\u00bbPoppins semibold|||on|||||\u00a0\u00bb header_font_size=\u00a0\u00bb36px\u00a0\u00bb custom_margin=\u00a0\u00bb14px||23px||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||30px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb header_font_size_phone=\u00a0\u00bb24px\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h1>Contact<\/h1>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_font=\u00a0\u00bbPoppins regular||||||||\u00a0\u00bb text_text_color=\u00a0\u00bb#393C84&Prime; text_font_size=\u00a0\u00bb24px\u00a0\u00bb text_line_height=\u00a0\u00bb1.33em\u00a0\u00bb module_alignment=\u00a0\u00bbright\u00a0\u00bb custom_margin=\u00a0\u00bb||0px||false|false\u00a0\u00bb text_font_size_tablet=\u00a0\u00bb\u00a0\u00bb text_font_size_phone=\u00a0\u00bb18px\u00a0\u00bb text_font_size_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>N&rsquo;h\u00e9sitez pas \u00e0 nous contacter si vous avez des questions ou des commentaires ! Nous vous r\u00e9pondrons dans les plus brefs d\u00e9lais. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb1_3,1_3,1_3&Prime; use_custom_gutter=\u00a0\u00bbon\u00a0\u00bb module_class=\u00a0\u00bbtablet-three-cols\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width_tablet=\u00a0\u00bb980px\u00a0\u00bb max_width_phone=\u00a0\u00bb500px\u00a0\u00bb max_width_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_padding=\u00a0\u00bb0px|30px|0px|30px|false|true\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_css_main_element_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_main_element_tablet=\u00a0\u00bbdisplay:flex;\u00a0\u00bb custom_css_main_element_phone=\u00a0\u00bbdisplay:flex; flex-direction:column;\u00a0\u00bb][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbbe0fba28-f74a-4ba0-9a8d-9cd30aca805d\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_css_main_element_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb custom_css_main_element_tablet=\u00a0\u00bbmargin-bottom:0;\u00a0\u00bb custom_css_main_element_phone=\u00a0\u00bbmargin-bottom:20px;\u00a0\u00bb][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Carin_Uyl-de-Groot.png\u00a0\u00bb title_text=\u00a0\u00bbCarin_Uyl-de-Groot\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bba348f9e0-d57b-4c22-b522-c52b784fe57f\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb link_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>Pour les questions relatives \u00e0 la recherche :<\/p>\n<p><strong>Carin Uyl-de Groot<\/strong><br \/>Coordinatrice de projet<\/p>\n<p>Universit\u00e9 Erasmus de Rotterdam<br \/><a href=\"mailto:uyl@eshpm.eur.nl\">uyl@eshpm.eur.nl<\/a><br \/>T\u00e9l\u00e9phone : +31 10 4081583<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbbe0fba28-f74a-4ba0-9a8d-9cd30aca805d\u00a0\u00bb background_color=\u00a0\u00bb#393C84&Prime; global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_css_main_element_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_main_element_tablet=\u00a0\u00bbmargin-bottom:0;\u00a0\u00bb custom_css_main_element_phone=\u00a0\u00bbmargin-bottom:20px;\u00a0\u00bb][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Marcel-Langone-1.png\u00a0\u00bb title_text=\u00a0\u00bbMarcel-Langone\u00a0\u00bb align=\u00a0\u00bbcenter\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bba348f9e0-d57b-4c22-b522-c52b784fe57f\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb link_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>Pour des questions g\u00e9n\u00e9rales sur le projet :<\/p>\n<p><strong>Marcel Langone Marques<\/strong><br \/>Chef de projet<\/p>\n<p>Universit\u00e9 Erasmus de Rotterdam<br \/><a href=\"mailto:marcel.langonemarques@eur.nl\">marcel.langonemarques@eur.nl<\/a><br \/>T\u00e9l\u00e9phone : +31 10 4081583<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbbe0fba28-f74a-4ba0-9a8d-9cd30aca805d\u00a0\u00bb background_color=\u00a0\u00bb#048EA3&Prime; global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/06\/My-project-1-7.png\u00a0\u00bb title_text=\u00a0\u00bbMon projet-1 (7)\u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bba348f9e0-d57b-4c22-b522-c52b784fe57f\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb link_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>Pour les communications :<\/p>\n<p><strong>Lena Jessen<\/strong><br \/>Chef de projet<\/p>\n<p>OptiMedis<br \/><a href=\"mailto:l.jessen@optimedis.de\">l.jessen@optimedis.de<\/a><br \/>T\u00e9l\u00e9phone : +49 40 226211490<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Impact L&rsquo;impact d&rsquo;ASCERTAIN sur les principaux acteurs du secteur de la sant\u00e9Le projet ASCERTAIN s&rsquo;adresse \u00e0 de multiples acteurs du secteur des soins de sant\u00e9, chacun ayant des besoins et des objectifs uniques. Pour les industriels, ASCERTAIN propose des recommandations pour l\u2019\u00e9valuation des technologies de la sant\u00e9 (ETS) et apporte de nouvelles connaissances sur la cr\u00e9ation de valeur, la tarification et l\u2019acc\u00e8s. Le projet vise \u00e0 aider l\u2019industrie \u00e0 prendre des d\u00e9cisions \u00e9clair\u00e9es concernant l\u2019accessibilit\u00e9 et la durabilit\u00e9 des technologies de sant\u00e9 innovantes (IHT). Les patients b\u00e9n\u00e9ficient du projet ASCERTAIN, qui vise \u00e0 acc\u00e9l\u00e9rer l&rsquo;acc\u00e8s aux technologies de sant\u00e9 innovantes et \u00e0 garantir une tarification \u00e9quitable. Le projet vise \u00e0 am\u00e9liorer le caract\u00e8re abordable et l&rsquo;accessibilit\u00e9 des technologies de sant\u00e9 innovantes et \u00e0 faire en sorte que les patients puissent b\u00e9n\u00e9ficier des derni\u00e8res avanc\u00e9es en mati\u00e8re de soins de sant\u00e9. Les chercheurs trouveront le projet ASCERTAIN particuli\u00e8rement utile car il offre un acc\u00e8s libre aux donn\u00e9es et un outil de politique d&rsquo;acc\u00e8s libre. L&rsquo;objectif du projet est de fournir aux chercheurs des informations pr\u00e9cieuses sur le d\u00e9veloppement de nouveaux mod\u00e8les de tarification et de remboursement et de soutenir l&rsquo;avancement de la recherche dans le domaine des soins de sant\u00e9. Les [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2558,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-3524","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.8 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Impact - ASCERTAIN<\/title>\n<meta name=\"description\" content=\"Comprenez comment ASCERTAIN aide les acteurs cl\u00e9s du secteur de la sant\u00e9 \u00e0 cr\u00e9er de la valeur, des prix et de l&#039;acc\u00e8s.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/fr\/impact\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Impact\" \/>\n<meta property=\"og:description\" content=\"Comprenez comment ASCERTAIN aide les acteurs cl\u00e9s du secteur de la sant\u00e9 \u00e0 cr\u00e9er de la valeur, des prix et de l&#039;acc\u00e8s.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/fr\/impact\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-24T07:56:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1132274611_iStock_PeopleImages.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1282\" \/>\n\t<meta property=\"og:image:height\" content=\"818\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/impact\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/impact\\\/\",\"name\":\"Impact - ASCERTAIN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/impact\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/impact\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Foto_1132274611_iStock_PeopleImages.jpg\",\"datePublished\":\"2023-03-03T16:32:40+00:00\",\"dateModified\":\"2025-06-24T07:56:05+00:00\",\"description\":\"Comprenez comment ASCERTAIN aide les acteurs cl\u00e9s du secteur de la sant\u00e9 \u00e0 cr\u00e9er de la valeur, des prix et de l'acc\u00e8s.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/impact\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/impact\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/impact\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Foto_1132274611_iStock_PeopleImages.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/Foto_1132274611_iStock_PeopleImages.jpg\",\"width\":1282,\"height\":818},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/impact\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/startseite\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Impact\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Impact - ASCERTAIN","description":"Comprenez comment ASCERTAIN aide les acteurs cl\u00e9s du secteur de la sant\u00e9 \u00e0 cr\u00e9er de la valeur, des prix et de l'acc\u00e8s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/fr\/impact\/","og_locale":"fr_FR","og_type":"article","og_title":"Impact","og_description":"Comprenez comment ASCERTAIN aide les acteurs cl\u00e9s du secteur de la sant\u00e9 \u00e0 cr\u00e9er de la valeur, des prix et de l'acc\u00e8s.","og_url":"https:\/\/www.access2meds.eu\/fr\/impact\/","og_site_name":"ASCERTAIN","article_modified_time":"2025-06-24T07:56:05+00:00","og_image":[{"width":1282,"height":818,"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1132274611_iStock_PeopleImages.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/fr\/impact\/","url":"https:\/\/www.access2meds.eu\/fr\/impact\/","name":"Impact - ASCERTAIN","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/fr\/impact\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/fr\/impact\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1132274611_iStock_PeopleImages.jpg","datePublished":"2023-03-03T16:32:40+00:00","dateModified":"2025-06-24T07:56:05+00:00","description":"Comprenez comment ASCERTAIN aide les acteurs cl\u00e9s du secteur de la sant\u00e9 \u00e0 cr\u00e9er de la valeur, des prix et de l'acc\u00e8s.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/fr\/impact\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/fr\/impact\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.access2meds.eu\/fr\/impact\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1132274611_iStock_PeopleImages.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1132274611_iStock_PeopleImages.jpg","width":1282,"height":818},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/fr\/impact\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/fr\/startseite\/"},{"@type":"ListItem","position":2,"name":"Impact"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/pages\/3524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/comments?post=3524"}],"version-history":[{"count":6,"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/pages\/3524\/revisions"}],"predecessor-version":[{"id":4497,"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/pages\/3524\/revisions\/4497"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/media\/2558"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/media?parent=3524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}